Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Trends Psychiatry Psychother ; 35(1): 81-4, 2013.
Article in English | MEDLINE | ID: mdl-25923189

ABSTRACT

OBJECTIVE: Near-death experiences have been defined as profound psychological events that may occur to a person while close to death or in a situation of extreme physical or emotional distress. These experiences seem to have an important effect on the patients' mental health and may occur in several situations despite their cultural and religious beliefs. CASE DESCRIPTION: The present case report describes the positive impact of a near-death experience (Greyson scale > 7) followed by religious conversion on the mental health of a former prisoner. COMMENTS: Investigation of the role of near-death experiences by the scientific community could shed light on the coping mechanisms and moral/ethical transformations that take place in these individuals.

2.
Trends psychiatry psychother. (Impr.) ; 35(1): 81-84, 2013. tab
Article in English | LILACS | ID: lil-676016

ABSTRACT

OBJECTIVE: Near-death experiences have been defined as profound psychological events that may occur to a person while close to death or in a situation of extreme physical or emotional distress. These experiences seem to have an important effect on the patients’ mental health and may occur in several situations despite their cultural and religious beliefs. CASE DESCRIPTION: The present case report describes the positive impact of a near-death experience (Greyson scale > 7) followed by religious conversion on the mental health of a former prisoner. COMMENTS: Investigation of the role of near-death experiences by the scientific community could shed light on the coping mechanisms and moral/ethical transformations that take place in these individuals


OBJETIVO: As experiências de quase-morte são definidas como eventos psicológicos profundos, que podem ocorrer quando uma pessoa está em morte iminente ou em situação de intensa crise física ou emocional. Essas experiências parecem ter efeito importante sobre a saúde mental desses pacientes e ocorrem em diversas situações, a despeito de culturas e crenças religiosas. RELATO DE CASO: O presente relato de caso descreve a influência positiva de uma experiência de quase-morte (escala de Greyson > 7) seguida de conversão religiosa sobre a saúde mental de um ex-detento. COMENTÁRIO: A investigação do papel de experiências de quase-morte em âmbito científico poderia ajudar a elucidar os mecanismos de coping e transformações éticas e morais que ocorrem nesses indivíduos


Subject(s)
Humans , Male , Middle Aged , Death , Religion and Medicine , Mental Health , Social Adjustment , Criminals/psychology
3.
Neuroimage ; 47(2): 467-72, 2009 Aug 15.
Article in English | MEDLINE | ID: mdl-19398020

ABSTRACT

Depression is the most frequent psychiatric disorder in Parkinson's disease (PD). Although evidence suggests that depression in PD is related to the degenerative process that underlies the disease, further studies are necessary to better understand the neural basis of depression in this population of patients. In order to investigate neuronal alterations underlying the depression in PD, we studied thirty-six patients with idiopathic PD. Twenty of these patients had the diagnosis of major depression disorder and sixteen did not. The two groups were matched for PD motor severity according to Unified Parkinson Disease Rating Scale (UPDRS). First we conducted a functional magnetic resonance imaging (fMRI) using an event-related parametric emotional perception paradigm with test retest design. Our results showed decreased activation in the left mediodorsal (MD) thalamus and in medial prefrontal cortex in PD patients with depression compared to those without depression. Based upon these results and the increased neuron count in MD thalamus found in previous studies, we conducted a region of interest (ROI) guided voxel-based morphometry (VBM) study comparing the thalamic volume. Our results showed an increased volume in mediodorsal thalamic nuclei bilaterally. Converging morphological changes and functional emotional processing in mediodorsal thalamus highlight the importance of limbic thalamus in PD depression. In addition this data supports the link between neurodegenerative alterations and mood regulation.


Subject(s)
Depression/diagnosis , Depression/pathology , Limbic System/pathology , Magnetic Resonance Imaging/methods , Parkinson Disease/complications , Parkinson Disease/diagnosis , Thalamus/pathology , Humans , Imaging, Three-Dimensional , Male , Middle Aged
4.
J Nerv Ment Dis ; 196(9): 671-7, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18791428

ABSTRACT

Previous studies have shown that patients with major depression have an interhemispheric imbalance between right and left prefrontal and motor cortex. We aimed to investigate the interhemispheric interactions in patients with major depression using repetitive transcranial magnetic stimulation (rTMS). Thirteen patients with major depression and 14 age-matched healthy subjects participated in this study. Corticospinal excitability before and after 1 Hz rTMS (applied to the left primary motor cortex) was assessed in the left and right motor cortex and these results were compared with those in healthy subjects. There was a significant difference in the interhemispheric effects between patients with depression and healthy subjects. In healthy subjects, 1 Hz rTMS significantly decreased corticospinal excitability in the stimulated, left hemisphere and increased it in the contralateral, right hemisphere. In depressed subjects, 1 Hz rTMS also decreased corticospinal excitability in the left hemisphere; however, it induced no significant changes in corticospinal excitability in the contralateral, right hemisphere. In addition, there was a significant correlation between the degree of interhemispheric modulation and the severity of the depression as indexed by the Beck Depression Inventory scores. Our findings showing a decreased interhemispheric modulation in patients with major depression are consistent with the notion that mood disorders are associated with slow interhemispheric switching mechanisms.


Subject(s)
Depressive Disorder, Major/physiopathology , Dominance, Cerebral/physiology , Adult , Affect/physiology , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/therapy , Female , Humans , Male , Middle Aged , Motor Cortex/physiopathology , Neural Inhibition/physiology , Personality Inventory , Pyramidal Tracts/physiopathology , Synaptic Transmission , Transcranial Magnetic Stimulation
5.
Int J Neuropsychopharmacol ; 11(2): 173-83, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17708780

ABSTRACT

The mechanisms underlying the effects of antidepressant treatment in patients with Parkinson's disease (PD) are unclear. The neural changes after successful therapy investigated by neuroimaging methods can give insights into the mechanisms of action related to a specific treatment choice. To study the mechanisms of neural modulation of repetitive transcranial magnetic stimulation (rTMS) and fluoxetine, 21 PD depressed patients were randomized into only two active treatment groups for 4 wk: active rTMS over left dorsolateral prefrontal cortex (DLPFC) (5 Hz rTMS; 120% motor threshold) with placebo pill and sham rTMS with fluoxetine 20 mg/d. Event-related functional magnetic resonance imaging (fMRI) with emotional stimuli was performed before and after treatment - in two sessions (test and re-test) at each time-point. The two groups of treatment had a significant, similar mood improvement. After rTMS treatment, there were brain activity decreases in left fusiform gyrus, cerebellum and right DLPFC and brain activity increases in left DLPFC and anterior cingulate gyrus compared to baseline. In contrast, after fluoxetine treatment, there were brain activity increases in right premotor and right medial prefrontal cortex. There was a significant interaction effect between groups vs. time in the left medial prefrontal cortex, suggesting that the activity in this area changed differently in the two treatment groups. Our findings show that antidepressant effects of rTMS and fluoxetine in PD are associated with changes in different areas of the depression-related neural network.


Subject(s)
Antidepressive Agents, Second-Generation/therapeutic use , Brain Mapping/methods , Depressive Disorder, Major/therapy , Fluoxetine/therapeutic use , Magnetic Resonance Imaging , Parkinson Disease/psychology , Prefrontal Cortex/drug effects , Transcranial Magnetic Stimulation , Affect/drug effects , Aged , Combined Modality Therapy , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/etiology , Depressive Disorder, Major/physiopathology , Emotions/drug effects , Evoked Potentials , Humans , Middle Aged , Parkinson Disease/drug therapy , Parkinson Disease/physiopathology , Parkinson Disease/therapy , Prefrontal Cortex/physiopathology , Psychiatric Status Rating Scales , Time Factors , Treatment Outcome
6.
Int J Neuropsychopharmacol ; 11(2): 249-54, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17559710

ABSTRACT

Preliminary findings suggest that transcranial direct current stimulation (tDCS) can have antidepressant effects. We sought to test this further in a parallel-group, double-blind clinical trial with 40 patients with major depression, medication-free randomized into three groups of treatment: anodal tDCS of the left dorsolateral prefrontal cortex (active group - 'DLPFC'); anodal tDCS of the occipital cortex (active control group - 'occipital') and sham tDCS (placebo control group - 'sham'). tDCS was applied for 10 sessions during a 2-wk period. Mood was evaluated by a blinded rater using the Hamilton Depression Rating Scale (HDRS) and Beck Depression Inventory (BDI). The treatment was well tolerated with minimal side-effects that were distributed equally across all treatment groups. We found significantly larger reductions in depression scores after DLPFC tDCS [HDRS reduction of 40.4% (+/-25.8%)] compared to occipital [HDRS reduction of 21.3% (+/-12.9%)] and sham tDCS [HDRS reduction of 10.4% (+/-36.6%)]. The beneficial effects of tDCS in the DLPFC group persisted for 1 month after the end of treatment. Our findings support further investigation on the effects of this novel potential therapeutic approach - tDCS - for the treatment of major depression.


Subject(s)
Depressive Disorder, Major/therapy , Electric Stimulation Therapy , Prefrontal Cortex/physiopathology , Adult , Affect , Depressive Disorder, Major/physiopathology , Double-Blind Method , Electric Stimulation Therapy/adverse effects , Female , Humans , Male , Middle Aged , Occipital Lobe/physiopathology , Psychiatric Status Rating Scales , Time Factors , Treatment Outcome
8.
Pain Pract ; 7(4): 297-306, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17986164

ABSTRACT

OBJECTIVE: To investigate whether active anodal transcranial direct current stimulation (tDCS) (of dorsolateral prefrontal cortex [DLPFC] and primary motor cortex [M1]) as compared to sham treatment is associated with changes in sleep structure in fibromyalgia. METHODS: Thirty-two patients were randomized to receive sham stimulation or active tDCS with the anode centered over M1 or DLPFC (2 mA, 20 minutes for five consecutive days). A blinded evaluator rated the clinical symptoms of fibromyalgia. All-night polysomnography was performed before and after five consecutive sessions of tDCS. RESULTS: Anodal tDCS had an effect on sleep and pain that was specific to the site of stimulation: such as that M1 and DLPFC treatments induced opposite effects on sleep and pain, whereas sham stimulation induced no significant sleep or pain changes. Specifically, whereas M1 treatment increased sleep efficiency (by 11.8%, P = 0.004) and decreased arousals (by 35.0%, P = 0.001), DLPFC stimulation was associated with a decrease in sleep efficiency (by 7.5%, P = 0.02), an increase in rapid eye movement (REM) and sleep latency (by 47.7%, P = 0.0002, and 133.4%, P = 0.02, respectively). In addition, a decrease in REM latency and increase in sleep efficiency were associated with an improvement in fibromyalgia symptoms (as indexed by the Fibromyalgia Impact Questionnaire). Finally, patients with higher body mass index had the worse sleep outcome as indexed by sleep efficiency changes after M1 stimulation. INTERPRETATION: Our findings suggest that one possible mechanism to explain the therapeutic effects of tDCS in fibromyalgia is via sleep modulation that is specific to modulation of primary M1 activity.


Subject(s)
Fibromyalgia/therapy , Pain Management , Sleep Wake Disorders/therapy , Transcranial Magnetic Stimulation , Adult , Female , Fibromyalgia/complications , Fibromyalgia/physiopathology , Humans , Middle Aged , Motor Cortex/physiology , Pain/etiology , Pain/physiopathology , Prefrontal Cortex/physiology , Sleep Wake Disorders/etiology , Sleep Wake Disorders/physiopathology , Sleep, REM/physiology
9.
J Clin Psychiatry ; 68(10): 1528-32, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17960967

ABSTRACT

OBJECTIVE: To study the therapeutic effects on auditory hallucinations refractory to clozapine with 1-Hz repetitive transcranial magnetic stimulation (rTMS) applied on the left temporoparietal cortex. METHOD: Eleven patients with schizophrenia (DSM-IV) experiencing auditory hallucinations (unresponsive to clozapine) were randomly assigned to receive either active of rTMS (N = 6) or sham stimulation (N = 5) (with concomitant use of clozapine) using a double-masked, sham-controlled, parallel design. A total of 160 minutes of rTMS (9600 pulses) was administered over 10 days at 90% motor threshold. The study was conducted from January 2003 to December 2005. RESULTS: There was a reduction in hallucination scores in both groups, which persisted during follow-up in the active group for the items reality (p = .0493) and attentional salience (p = .0360). Both groups showed similar patterns of symptomatic changes on subscales (negative symptoms, general psychopathology) and total scores of the Positive and Negative Syndrome Scale, Clinical Global Impressions scale, and Visual Analog Scale. CONCLUSION: Active rTMS in association with clozapine can be administered safely to treat auditory hallucinations, although its clinical utility is still questionable. No significant clinical effects were observed in the sample studied, possibly because it was too small and/or due to its high refractoriness.


Subject(s)
Clozapine/therapeutic use , Drug Resistance , Hallucinations/drug therapy , Hallucinations/etiology , Schizophrenia/diagnosis , Schizophrenia/therapy , Schizophrenic Psychology , Transcranial Magnetic Stimulation/methods , Adult , Demography , Diagnostic and Statistical Manual of Mental Disorders , Double-Blind Method , Female , Hallucinations/epidemiology , Humans , Male , Severity of Illness Index , Treatment Outcome
10.
Restor Neurol Neurosci ; 25(2): 123-9, 2007.
Article in English | MEDLINE | ID: mdl-17726271

ABSTRACT

PURPOSE: Recent evidence has suggested that a simple technique of noninvasive brain stimulation - transcranial direct current stimulation (tDCS) - is associated with a significant motor function improvement in stroke patients. METHODS: We tested the motor performance improvement in stroke patients following 4 weekly sessions of sham, anodal- and cathodal tDCS (experiment 1) and the effects of 5 consecutive daily sessions of cathodal tDCS (experiment 2). A blinded rater evaluated motor function using the Jebsen-Taylor Hand Function Test. RESULTS: There was a significant main effect of stimulation condition (p=0.009) in experiment 1. Furthermore there was a significant motor function improvement after either cathodal tDCS of the unaffected hemisphere (p=0.016) or anodal tDCS of the affected hemisphere (p=0.046) when compared to sham tDCS. There was no cumulative effect associated with weekly sessions of tDCS, however consecutive daily sessions of tDCS (experiment 2) were associated with a significant effect on time (p< 0.0001) that lasted for 2 weeks after treatment. CONCLUSIONS: The findings of our study support previous research showing that tDCS is significantly associated with motor function improvement in stroke patients; and support that consecutive daily sessions of tDCS might increase its behavioral effects. Because the technique of tDCS is simple, safe and non-expensive; our findings support further research on the use of this technique for the rehabilitation of patients with stroke.


Subject(s)
Electric Stimulation Therapy , Movement , Stroke Rehabilitation , Stroke/physiopathology , Adult , Aged , Female , Humans , Male , Middle Aged , Single-Blind Method , Treatment Outcome
11.
Dev Med Child Neurol ; 49(7): 534-8, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17593127

ABSTRACT

The development of non-invasive techniques of cortical stimulation, such as transcranial magnetic stimulation (TMS), has opened new potential avenues for the treatment of neuropsychiatric diseases. We hypothesized that an increase in the activity in the motor cortex by cortical stimulation would increase its inhibitory influence on spinal excitability through the corticospinal tract and, thus, reduce the hyperactivity of the gamma and alpha neurons, improving spasticity. Seventeen participants (eight males, nine females; mean age 9y 1mo [SD 3y 2mo]) with cerebral palsy and spastic quadriplegia were randomized to receive sham, active 1Hz, or active 5Hz repetitive TMS of the primary motor cortex. Stimulation was applied for 5 consecutive days (90% of motor threshold). The results showed that there was a significant reduction of spasticity after 5Hz, but not sham or 1Hz, stimulation as indexed by the degree of passive movement; however this was not evident when using the Ashworth scale, although a trend for improvement was seen for elbow movement. The safety evaluation showed that stimulation with either 1Hz or 5Hz did not result in any adverse events as compared with sham stimulation. Results of this trial provide initial evidence to support further trials exploring the use of cortical stimulation in the treatment of spasticity.


Subject(s)
Cerebral Palsy/therapy , Quadriplegia/therapy , Transcranial Magnetic Stimulation/methods , Adolescent , Analysis of Variance , Child , Dose-Response Relationship, Radiation , Double-Blind Method , Electric Stimulation/methods , Female , Humans , Male , Severity of Illness Index , Treatment Outcome
12.
J Affect Disord ; 101(1-3): 91-8, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17166593

ABSTRACT

BACKGROUND: We recently showed that repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex (DLPFC) can affect the performance in an affective go-no-go (AGN) task. We aimed to extend this previous investigation testing whether one session of anodal transcranial direct current stimulation (tDCS) of the left DLPFC, as compared with anodal occipital and sham tDCS, affects this AGN task performance. METHODS: Twenty-six patients with major depression were randomized to receive anodal tDCS of the left DLPFC, occipital cortex or sham tDCS (the cathode electrode was placed over the frontopolar area for the three conditions). An AGN task was performed immediately before and after treatment. Performance changes (pre and post-treatment) were compared across groups of treatment and correlated with Hamilton Depression Rating Scale (HDRS) score changes. RESULTS: The results show that anodal stimulation of the left DLPFC was the only condition that induced a significant improvement in task performance as shown by the increase in the number of correct responses. In addition, this effect was specific for figures with positive emotional content. This performance enhancement was not correlated with mood changes after 10 days of tDCS treatment. LIMITATIONS: Although the effects of tDCS are less focal than rTMS, it can induce a longer and stronger modulation of cortical excitability. CONCLUSIONS: Our findings suggest that left DLPFC activity is associated with positive emotional processing, confirming and extending results of previous studies that associated right DLPFC and orbito-frontal cortex activity with emotional processing. Furthermore the effects of tDCS on mood and cognition seem to be independent in major depression. These lines of evidence together shed light on the neural circuitry involved with emotional processing in major depression.


Subject(s)
Attention/physiology , Depressive Disorder, Major/therapy , Dominance, Cerebral/physiology , Electric Stimulation Therapy , Inhibition, Psychological , Neuropsychological Tests , Prefrontal Cortex/physiopathology , Adult , Affect/physiology , Arousal/physiology , Brain Mapping , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/psychology , Female , Humans , Male , Middle Aged , Nerve Net/physiopathology , Occipital Lobe/physiopathology , Pattern Recognition, Visual/physiology , Psychomotor Performance/physiology , Reaction Time/physiology
13.
Arthritis Rheum ; 54(12): 3988-98, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17133529

ABSTRACT

OBJECTIVE: Recent evidence suggests that fibromyalgia is a disorder characterized by dysfunctional brain activity. Because transcranial direct current stimulation (tDCS) can modulate brain activity noninvasively and can decrease pain in patients with refractory central pain, we hypothesized that tDCS treatment would result in pain relief in patients with fibromyalgia. METHODS: Thirty-two patients were randomized to receive sham stimulation or real tDCS with the anode centered over the primary motor cortex (M1) or the dorsolateral prefrontal cortex (DLPFC) (2 mA for 20 minutes on 5 consecutive days). A blinded evaluator rated the patient's pain, using the visual analog scale for pain, the clinician's global impression, the patient's global assessment, and the number of tender points. Other symptoms of fibromyalgia were evaluated using the Fibromyalgia Impact Questionnaire and the Short Form 36 Health Survey. Safety was assessed with a battery of neuropsychological tests. To assess potential confounders, we measured mood and anxiety changes throughout the trial. RESULTS: Anodal tDCS of the primary motor cortex induced significantly greater pain improvement compared with sham stimulation and stimulation of the DLPFC (P < 0.0001). Although this effect decreased after treatment ended, it was still significant after 3 weeks of followup (P = 0.004). A small positive impact on quality of life was observed among patients who received anodal M1 stimulation. This treatment was associated with a few mild adverse events, but the frequency of these events in the active-treatment groups was similar to that in the sham group. Cognitive changes were similar in all 3 treatment groups. CONCLUSION: Our findings provide initial evidence of a beneficial effect of tDCS in fibromyalgia, thus encouraging further trials.


Subject(s)
Electric Stimulation Therapy/methods , Fibromyalgia/therapy , Pain Management , Chronic Disease , Female , Fibromyalgia/complications , Fibromyalgia/physiopathology , Humans , Middle Aged , Pain/complications , Pain/etiology , Pain/physiopathology , Pain Measurement , Prefrontal Cortex , Quality of Life , Single-Blind Method , Treatment Outcome
14.
Am J Phys Med Rehabil ; 85(11): 927-30, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17079967

ABSTRACT

Previous research has shown that low-frequency rTMS of the unaffected hemisphere can improve motor function in acute and chronic stroke patients. However, these studies only investigated patients with mild or moderate motor deficits. We report a case of a stroke patient with a severe motor impairment who underwent sham and active repetitive transcranial magnetic stimulation (rTMS) of the unaffected hemisphere and had significantly improved motor function after active, but not after sham, stimulation of the unaffected primary motor cortex. In an additional session of active rTMS, this patient maintained and further enhanced the initial motor improvement. This case report shows that inhibitory rTMS of the unaffected hemisphere can also be beneficial for stroke patients with severe motor deficits and suggests that this approach of noninvasive brain stimulation should be further investigated in this population of patients.


Subject(s)
Paralysis/rehabilitation , Stroke Rehabilitation , Transcranial Magnetic Stimulation , Aged , Evoked Potentials, Motor , Female , Hand , Humans , Paralysis/etiology , Pilot Projects , Stroke/complications
15.
Ann Neurol ; 60(4): 447-55, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17068786

ABSTRACT

OBJECTIVE: To study the antiepileptic effects of rTMS in patients with refractory epilepsy and malformations of cortical development in a randomized, double-blind, sham-controlled trial. METHODS: Twenty-one patients with malformations of cortical development and refractory epilepsy underwent five consecutive sessions of low-frequency rTMS, either sham or active (1Hz, 1,200 pulses), focally targeting the malformations of cortical development. The number of epileptiform discharges in the electroencephalogram and the number of clinical seizures were measured before (baseline), immediately after, as well as 30 and 60 days after rTMS treatment. RESULTS: rTMS significantly decreased the number of seizures in the active compared with sham rTMS group (p < 0.0001), and this effect lasted for at least 2 months. Furthermore, there was a significant decrease in the number of epileptiform discharges immediately after (p = 0.01) and at week 4 (p = 0.03) in the active rTMS group only. There were few mild adverse effects equally distributed in both groups. The preliminary cognitive evaluation suggests improvement in some aspects of cognition in the active rTMS group only. INTERPRETATION: Noninvasive brain stimulation for epilepsy may be an alternative treatment for pharmaco-resistant patients with clearly identifiable seizure foci in the cortical convexity and who are not eligible for surgical treatment.


Subject(s)
Epilepsy/therapy , Transcranial Magnetic Stimulation , Adult , Cognition/physiology , Data Interpretation, Statistical , Double-Blind Method , Drug Resistance , Electroencephalography , Epilepsy/drug therapy , Epilepsy/psychology , Female , Humans , Interpersonal Relations , Male , Neuropsychological Tests , Psychomotor Performance/physiology , Reaction Time/physiology , Seizures/etiology , Seizures/physiopathology , Treatment Outcome
16.
Eur Neurol ; 56(4): 222-9, 2006.
Article in English | MEDLINE | ID: mdl-17057382

ABSTRACT

BACKGROUND: A recent well-conducted meta-analysis showed that placebo effect is associated with a possible small benefit for subjective outcomes, but has no significant effects on objective outcomes. OBJECTIVE: Herein, we aimed to investigate the immediate effects of two different types of placebo [placebo pill and sham transcranial magnetic stimulation (TMS)] in Parkinson's disease (PD) patients and compared them to the standard treatment (levodopa) in a proper randomized, double-blind, crossover clinical trial. METHODS: PD patients received three different interventions on different days: levodopa, placebo pill, and sham TMS. The motor function was assessed using simple and choice reaction time, Unified Parkinson's Disease Rating Scale (UPDRS), finger tapping, Purdue Pegboard test, time to button up, walking time and supination-pronation. The subjective motor function was measured by a visual analogue scale (VAS). RESULTS: The results showed that there was a significant motor function in the motor function only after the treatment with levodopa, but not after treatment with placebo pills or sham TMS. However, patients reported a similar subjective improvement in motor function indexed by VAS following these three treatments. CONCLUSION: These results suggest that placebo interventions in PD may have an immediate subjective sensation of improvement but result in no significant objective motor changes compared with levodopa treatment. Although physiological changes are possible after a placebo intervention, our findings suggest that the acute placebo effect in PD may be the result of the subjective change in the motor rating only.


Subject(s)
Antiparkinson Agents/therapeutic use , Levodopa/therapeutic use , Motor Skills/drug effects , Parkinson Disease/psychology , Parkinson Disease/therapy , Placebo Effect , Aged , Double-Blind Method , Female , Humans , Male , Middle Aged , Placebos/therapeutic use , Reaction Time/drug effects , Transcranial Magnetic Stimulation
17.
Int J Neuropsychopharmacol ; 9(6): 641-54, 2006 Dec.
Article in English | MEDLINE | ID: mdl-16939662

ABSTRACT

Although previous clinical trials have suggested that repetitive transcranial magnetic stimulation (rTMS) has a significant antidepressant effect, the results of these trials are heterogeneous. We hypothesized that individual patients' characteristics might contribute to such heterogeneity. Our aim was to identify predictors of antidepressant response to rTMS. We pooled data from six separate clinical trials conducted independently, which evaluated the effects of rapid rTMS of the left dorsolateral prefrontal cortex in patients with major depression. We investigated 195 patients with regard to demographic, depression and treatment characteristics, psychiatric and drug history. Results showed that age and treatment refractoriness were significant negative predictors of depression improvement when adjusting these variables to other significant predictors and confounders. These findings were not confounded by methodological differences from the six studies, as the results were adjusted for the study site. In conclusion TMS antidepressant therapy in younger and less treatment-resistant patients is associated with better outcome.


Subject(s)
Depressive Disorder, Major/therapy , Transcranial Magnetic Stimulation , Adolescent , Adult , Aged , Aged, 80 and over , Aging/psychology , Antidepressive Agents/therapeutic use , Depressive Disorder, Major/psychology , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Psychiatric Status Rating Scales , Randomized Controlled Trials as Topic , Treatment Outcome
18.
Neurosci Lett ; 404(1-2): 232-6, 2006 Aug 14.
Article in English | MEDLINE | ID: mdl-16808997

ABSTRACT

Transcranial direct current stimulation (tDCS) is a non-invasive powerful method to modulate brain activity. It can enhance motor learning and working memory in healthy subjects. To investigate the effects of anodal tDCS (1 mA, 20 min) of the dominant and non-dominant primary motor cortex (M1) on hand motor performance in healthy right-handed volunteers, healthy subjects underwent one session of both sham and active anodal stimulation of the non-dominant or dominant primary motor cortex. A blinded rater assessed motor function using the Jebsen Taylor Hand Function Test. For the non-dominant hand, active tDCS was able to improve motor function significantly-there was a significant interaction between time and condition of stimulation (p = 0.003). Post hoc tests showed a significant enhancement of JTT performance after 1 mA anodal tDCS of M1 (mean improvement of 9.41%, p = 0.0004), but not after sham tDCS (mean improvement of 1.3%, p = 0.84). For the dominant hand, however, neither active nor sham tDCS resulted in a significant change in motor performance. Our findings show that anodal tDCS of the non-dominant primary motor cortex results in motor function enhancement and thus confirm and extend the notion that tDCS can change behavior. We speculate that the under-use of the non-dominant hand with its associated consequences in cortical plasticity might be one of the reasons to explain motor performance enhancement in the non-dominant hand only.


Subject(s)
Brain/physiology , Dominance, Cerebral , Hand/innervation , Motor Activity/physiology , Adult , Electric Stimulation , Female , Humans , Reference Values , Weight-Bearing
19.
Mov Disord ; 21(10): 1693-702, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16817194

ABSTRACT

Electrical stimulation of deep brain structures, such as globus pallidus and subthalamic nucleus, is widely accepted as a therapeutic tool for patients with Parkinson's disease (PD). Cortical stimulation either with epidural implanted electrodes or repetitive transcranial magnetic stimulation can be associated with motor function enhancement in PD. We aimed to study the effects of another noninvasive technique of cortical brain stimulation, transcranial direct current stimulation (tDCS), on motor function and motor-evoked potential (MEP) characteristics of PD patients. We tested tDCS using different electrode montages [anodal stimulation of primary motor cortex (M1), cathodal stimulation of M1, anodal stimulation of dorsolateral prefrontal cortex (DLPFC), and sham-stimulation] and evaluated the effects on motor function--as indexed by Unified Parkinson's Disease Rating Scale (UPDRS), simple reaction time (sRT) and Purdue Pegboard test--and on corticospinal motor excitability (MEP characteristics). All experiments were performed in a double-blinded manner. Anodal stimulation of M1 was associated with a significant improvement of motor function compared to sham-stimulation in the UPDRS (P < 0.001) and sRT (P = 0.019). This effect was not observed for cathodal stimulation of M1 or anodal stimulation of DLPFC. Furthermore, whereas anodal stimulation of M1 significantly increased MEP amplitude and area, cathodal stimulation of M1 significantly decreased them. There was a trend toward a significant correlation between motor function improvement after M1 anodal-tDCS and MEP area increase. These results confirm and extend the notion that cortical brain stimulation might improve motor function in patients with PD.


Subject(s)
Deep Brain Stimulation/methods , Motor Cortex/physiopathology , Parkinson Disease/therapy , Prefrontal Cortex/physiopathology , Aged , Antiparkinson Agents/therapeutic use , Brain Mapping , Dominance, Cerebral/physiology , Double-Blind Method , Electrodes , Evoked Potentials, Motor/physiology , Female , Humans , Levodopa/therapeutic use , Male , Middle Aged , Motor Activity/physiology , Motor Skills/physiology , Neurologic Examination , Parkinson Disease/physiopathology , Statistics as Topic
20.
Stroke ; 37(8): 2115-22, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16809569

ABSTRACT

BACKGROUND AND PURPOSE: It has been recently shown that a single session of repetitive transcranial magnetic stimulation (rTMS) of the unaffected hemisphere can improve motor function in stroke patients; however, this improvement is short-lasting. We therefore conducted a randomized, sham-controlled, phase II trial to evaluate whether five sessions of low-frequency rTMS can increase the magnitude and duration of these effects and whether this approach is safe. METHODS: Fifteen patients with chronic stroke were randomized to receive active or sham rTMS of the unaffected hemisphere. A blinded rater assessed motor function and corticospinal excitability at baseline, during and after 2 weeks of treatment. Safety was assessed using a neuropsychologic battery and electroencephalogram. RESULTS: Active rTMS resulted in a significant improvement of the motor function performance in the affected hand that lasted for 2 weeks. These effects were not observed in the sham rTMS group (affected and unaffected hand) and in the unaffected hand in the active rTMS group. Corticospinal excitability decreased in the stimulated, unaffected hemisphere and increased in the affected hemisphere. There was a significant correlation between motor function improvement and corticospinal excitability change in the affected hemisphere. Cognitive performance and electroencephalogram were not changed significantly throughout the trial in both groups of treatment. CONCLUSIONS: These results support and extend the findings of previous studies on rTMS in stroke patients because five consecutive sessions of rTMS increased the magnitude and duration of the motor effects. Furthermore, this increased dose of rTMS is not associated with cognitive adverse effects and/or epileptogenic activity.


Subject(s)
Movement , Pyramidal Tracts/physiopathology , Stroke/physiopathology , Stroke/therapy , Transcranial Magnetic Stimulation , Adult , Aged , Cognition , Electroencephalography , Female , Hand/physiopathology , Humans , Male , Middle Aged , Single-Blind Method , Stroke/psychology , Time Factors , Transcranial Magnetic Stimulation/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...